Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
QIAGEN Seeks U.S. Regulatory Clearance for Full QIAsymphony RGQ MDx Workflow
Friday, January 31, 2014
Diagnostic workflow for C. difficile is launched in Europe and submitted in the U.S. for 510(k) clearance as the first of several new kits in QIAGEN’s pipeline for HAI.

First Blood Collection Tube for IVD Genomic DNA Testing Now Available
Wednesday, January 29, 2014
BD launches the PAXgene® Blood DNA Tube in Europe.

Improved Diagnosis of Sepsis-related Hepatic Dysfunction with the LiMAx Test
Monday, January 27, 2014
Prospective study showed superior sensitivity and specificity of the LiMAx test compared to traditional tests and its value as predictor of survival.

Massachusetts General Hospital Adopts Advanced Analytical Technology in Fight Against Cancer
Thursday, January 16, 2014
Company's Fragment Analyzer evaluates DNA and RNA of cancer patients.

Techne’s New Range of Dri-block® Heaters Given a New Look and Increased Functionality
Thursday, January 16, 2014
Enhanced levels of choice, flexibility and specification are offered.

Free Stool DNA Extraction Kits with Each DiaSorin LIAISON® Ixt/Arrow™ Instrument
Wednesday, January 15, 2014
An ideal opportunity to experience how LIAISON® Ixt/Arrow™ magnetic bead technology overcomes the difficulties of extracting highly purified DNA from stool samples.

Analytik Jena Develops Innovative Technology
Monday, January 13, 2014
Highly efficient enrichment of free-circulating DNA.

EKF Diagnostics’ Quo-Lab HbA1c Analyzer Secures IFCC Certification
Friday, January 10, 2014
Point-of-care analyzer meets all standards set by independent certifying bodies.

EKF Diagnostics Exhibits New POC Testing Technology at Arab Health
Wednesday, January 08, 2014
HbA1c and ß-HB analyzers enable rapid assessment of diabetes and related conditions.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 469
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv